Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-035352
Filing Date
2025-04-16
Accepted
2025-04-16 09:34:19
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2512441-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2512441-1_4seq1.xml 4 6944
  Complete submission text file 0001104659-25-035352.txt   8440
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791
Business Address
Sabba Stephen L (Reporting) CIK: 0001442372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 25841420